Prostate cancer is hormone. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Cell Line Pituitary Gland Cell Nucleus Stromal Cells Rectum Neoplastic Cells, Circulating

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases31

Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Neoplasm Metastasis Adenocarcinoma Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Carcinoma Lung Neoplasms Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Neovascularization, Pathologic Urinary Bladder Neoplasms Disease Models, Animal Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating

Chemicals and Drugs86

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Hormones Thyroid Hormones Tumor Markers, Biological Follicle Stimulating Hormone Gonadotropin-Releasing Hormone Luteinizing Hormone Tosyl Compounds Gonadal Steroid Hormones RNA, Messenger Antineoplastic Agents, Hormonal Antineoplastic Agents Parathyroid Hormone Androgen Receptor Antagonists Neoplasm Proteins Dihydrotestosterone Anilides Testosterone Finasteride Metribolone Flutamide Receptors, Thyroid Hormone RNA, Small Interfering Human Growth Hormone Anticarcinogenic Agents Cancer Vaccines Adrenocorticotropic Hormone Taxoids Estradiol Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors DNA, Neoplasm PTEN Phosphohydrolase Pituitary Hormones Testosterone Congeners Transcription Factors Nitriles Leuprolide 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Androstenols Antineoplastic Agents, Phytogenic Antigens, Neoplasm Estrogens Receptors, Estrogen Azasteroids Proto-Oncogene Proteins c-akt Phenylthiohydantoin Triiodothyronine Insulin-Like Growth Factor I RNA, Neoplasm Goserelin DNA-Binding Proteins Juvenile Hormones Racemases and Epimerases Tumor Suppressor Protein p53 Growth Hormone-Releasing Hormone Cholestenone 5 alpha-Reductase MicroRNAs Receptor, erbB-2 Estramustine Tumor Suppressor Proteins Prolactin Steroid 17-alpha-Hydroxylase Glutathione S-Transferase pi DNA Primers Receptors, Progesterone Enzyme Inhibitors Peptide Hormones Insulin-Like Growth Factor Binding Protein 3 Proto-Oncogene Proteins Antibodies, Monoclonal Androgen-Binding Protein Corticotropin-Releasing Hormone Proto-Oncogene Proteins c-bcl-2 Kallikreins Thyroxine Prostatic Secretory Proteins Anti-Mullerian Hormone Nuclear Proteins Paclitaxel Hypothalamic Hormones Trans-Activators Oncogene Proteins, Fusion

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Prostatectomy Orchiectomy Early Detection of Cancer Neoplasm Grading Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Prognosis Risk Factors Xenograft Model Antitumor Assays Digital Rectal Examination Immunohistochemistry Neoplasm Transplantation Transplantation, Heterologous Blotting, Western Case-Control Studies Gene Expression Profiling Prospective Studies Risk Follow-Up Studies Transurethral Resection of Prostate Risk Assessment Retrospective Studies Biopsy Survival Rate Castration Sensitivity and Specificity Survival Analysis Transfection Treatment Outcome Biopsy, Needle Odds Ratio Cohort Studies Incidence Brachytherapy Oligonucleotide Array Sequence Analysis Tumor Burden Combined Modality Therapy Disease-Free Survival Tissue Array Analysis Multivariate Analysis Predictive Value of Tests Antineoplastic Combined Chemotherapy Protocols SEER Program Hormone Replacement Therapy Polymerase Chain Reaction Registries Radiotherapy Models, Biological Logistic Models Reproducibility of Results Kaplan-Meier Estimate Nomograms Molecular Targeted Therapy Drug Screening Assays, Antitumor Radiotherapy Dosage Questionnaires Radiotherapy, Conformal Disease Models, Animal Immunoenzyme Techniques Gene Knockdown Techniques Confidence Intervals Mass Screening Clinical Trials as Topic Flow Cytometry In Situ Hybridization, Fluorescence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Psychiatry and Psychology1

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Signal Transduction Risk Cell Growth Processes Down-Regulation Cell Division Drug Resistance, Neoplasm Time Factors Sensitivity and Specificity Genotype Transfection Cell Survival Dose-Response Relationship, Drug Promoter Regions, Genetic Odds Ratio Cell Movement Up-Regulation Mutation Base Sequence DNA Methylation Polymorphism, Genetic Cell Cycle Gene Expression Transcription, Genetic Gene Silencing RNA Interference Nomograms Gene Fusion Genes, Tumor Suppressor Phosphorylation Chromosomes, Human, Pair 8 Diet Polymorphism, Single Nucleotide Alleles Phenotype Drug Synergism Genes, Neoplasm Amino Acid Sequence Protein Binding Transcriptional Activation Germ-Line Mutation Enzyme Activation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Molecular Sequence Data Base Sequence SEER Program Registries Questionnaires Radiotherapy, Conformal Amino Acid Sequence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care30

Risk Factors Watchful Waiting Case-Control Studies Prospective Studies Risk Follow-Up Studies Risk Assessment Retrospective Studies Survival Rate Sensitivity and Specificity Survival Analysis Treatment Outcome Odds Ratio Cohort Studies Incidence Age Factors Disease-Free Survival Multivariate Analysis Predictive Value of Tests SEER Program National Cancer Institute (U.S.)Registries Logistic Models Reproducibility of Results Kaplan-Meier Estimate Nomograms Questionnaires Confidence Intervals Mass Screening Clinical Trials as Topic

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Prostatic Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Hormones Prostatectomy Prostatic Hyperplasia Orchiectomy Gene Expression Regulation, Neoplastic Neoplasms, Hormone-Dependent Early Detection of Cancer Thyroid Hormones Tumor Markers, Biological Follicle Stimulating Hormone Neoplasm Metastasis Mice, Nude Adenocarcinoma Disease Progression Prostatic Intraepithelial Neoplasia Gonadotropin-Releasing Hormone Luteinizing Hormone Tosyl Compounds Bone Neoplasms Gonadal Steroid Hormones Neoplasm Invasiveness Cell Proliferation Neoplasm Grading RNA, Messenger Neoplasm Staging Antineoplastic Agents, Hormonal Tumor Cells, Cultured Reverse Transcriptase Polymerase Chain Reaction Apoptosis Antineoplastic Agents Parathyroid Hormone Genetic Predisposition to Disease Androgen Receptor Antagonists Neoplasm Proteins Prognosis Dihydrotestosterone Risk Factors Breast Neoplasms Xenograft Model Antitumor Assays Anilides Digital Rectal Examination Testosterone Immunohistochemistry Signal Transduction Neoplasm Transplantation Watchful Waiting Finasteride Transplantation, Heterologous Blotting, Western Case-Control Studies Neoplasms Gene Expression Profiling Prospective Studies Carcinoma Metribolone Risk Flutamide Follow-Up Studies Transurethral Resection of Prostate Lung Neoplasms Neoplasm Recurrence, Local Receptors, Thyroid Hormone Cell Growth Processes Down-Regulation Cell Division RNA, Small Interfering Risk Assessment Ovarian Neoplasms Human Growth Hormone Drug Resistance, Neoplasm Retrospective Studies Biopsy Prostatic Neoplasms, Castration-Resistant Survival Rate Time Factors Castration Sensitivity and Specificity Survival Analysis Anticarcinogenic Agents Genotype United States Transfection Cell Survival Cancer Vaccines Adrenocorticotropic Hormone Treatment Outcome Taxoids Dose-Response Relationship, Drug Promoter Regions, Genetic Estradiol Glutamate Carboxypeptidase II Colonic Neoplasms Biopsy, Needle

No FAQ available that match "prostate cancer is hormone"